Kodu・Aktsiate loetelu・Phreesia Inc

Phreesia Inc

Suletud

SektorTervishoid

11.21 4.57

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

10.64

Max

10.8

Põhinäitajad
By Trading Economics
Sissetulek	657K 3M
Müük	3.9M 131M
P/E Sektori keskmine	66.438 64.641
Aktsiakasum	0.19
Kasumimarginaal	2.263
Töötajad	1,789
EBITDA	12M 17M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+30.48% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	3. sept 2026

Turustatistika
By TradingEconomics
Turukapital	106M 657M
Eelmine avamishind	6.64
Eelmine sulgemishind	11.21

Uudiste sentiment

By Acuity

29%

71%

68 / 340 Pingereas Healthcare

Phreesia Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

31. juuli 2026, 19:34 UTC

Phreesia Inc is trading higher, supported by significant overall market gains. The stock is near the upper end of its one-month range.

30. juuli 2026, 17:41 UTC

News

Phreesia Inc. shares are lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving company officers and directors.

29. juuli 2026, 19:47 UTC

Phreesia Inc is trading higher, maintaining a strong position above its 20-day moving average amid mixed performance across major U.S. indices.

28. juuli 2026, 19:56 UTC

Phreesia Inc. shares are higher today, supported by gains in the Health Care Technology sub-sector, despite retracing from earlier session highs.

27. juuli 2026, 17:02 UTC

Phreesia Inc is trading higher today, driven by a significant advance in the Health Care Technology sub-sector, with shares near the upper end of their one-month range.

24. juuli 2026, 14:42 UTC

Phreesia Inc's shares are higher during Friday's session, rebounding from earlier lows after five consecutive declines. No specific news was identified for this movement.

23. juuli 2026, 20:03 UTC

News

Correlated Moves

Phreesia Inc partners with March of Dimes to enhance maternal health education, but shares are lower amid scrutiny from an ongoing investigation.

22. juuli 2026, 18:01 UTC

Correlated Moves

Phreesia Inc. shares are lower as first-quarter results show a notable decline, continuing a trend of four consecutive sessions finishing lower.

20. juuli 2026, 17:16 UTC

Correlated Moves

Phreesia Inc. shares are lower amid broader market pressures and a decline in the ARK Genomic Revolution ETF. Earlier, shares reached a session low.

Võrdlus sarnastega

Hinnamuutus

Phreesia Inc Prognoos

Hinnasiht

By TipRanks

30.48% tõus

12 kuu keskmine prognoos

Keskmine 14 USD 30.48%

Kõrge 20 USD

Madal 9 USD

Põhineb 13 Wall Streeti analüütiku instrumendi Phreesia Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

13 ratings

Osta

Hoia

Müü

Põhineb 13 analüütiku instrumendi Phreesia Inc aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

68 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.